Winterdepression – Mikronährstofftherapie

Menschen mit Winterdepression gehören zu einer Risikogruppe, die anfälliger für einen Mangel folgender Vitalstoffe* ist

Winterdepression als Mangelsymptom kann ein auf eine unzureichende Versorgung folgender Vitalstoffe* hinweisen:

Im Rahmen der Mikronährstoffmedizin werden zur unterstützenden Therapie bei Winterdepression folgende Vitalstoffe* eingesetzt:

Detaillierte Informationen zu den einzelnen Mikronährstoffen finden Sie im DocMedicus Vitalstofflexikon.

Die obigen Vitalstoff-Empfehlungen (Mikronährstoffe) wurden mithilfe des DocMedicus Expertensystems erstellt. Sämtliche Aussagen des Expertensystems sind durch Literatur mit hohen Evidenzgraden belegt.
Für eine Therapieempfehlung wurden nur klinische Studien mit den höchsten Evidenzgraden (Grad 1a/1b und 2a/2b) verwendet, die aufgrund ihrer hohen Aussagekraft die Therapieempfehlung belegen.

Hinweis!
Diese Daten werden in gewissen Zeitabständen aktualisiert.
Das DocMedicus Expertensystem ist stets auf dem aktuellen Stand der Vitalstoff-Forschung. Lassen Sie sich deshalb Ihre persönliche Vitalstoff-Analyse* mithilfe des DocMedicus Expertensystems bei Ihrem Arzt erstellen.

*Makronährstoffe (Kohlenhydrate, Fette, Proteine (Eiweiße)) und Mikronährstoffe (Vitamine, Mineralstoffe, Spurenelemente) sowie weitere Stoffe mit ernährungsspezifischer und physiologischer Wirkung

Vitalstoff-Analyse für den Mann
Vitalstoff-Analyse für die Frau

 Männergesundheit – Vitalstoff-Analyse
Frauengesundheit – Vitalstoff-Analyse

Literatur

  1. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008 Dez; 264, 6: 599-609.
  2. Anglin Rebecca E S, Samaan Zainab, Walter Stephen D, McDonald Sarah D. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb; 202: 100-7.
  3. Mizoue T, Kochi T, Akter S, Eguchi M, Kurotani K, Tsuruoka H, Kuwahara K, Ito R, Kabe I, Nanri A. Low serum 25-hydroxyvitamin D concentrations are associated with increased likelihood of having depressive symptoms among Japanese workers. J Nutr. 2015 Mar;145(3):541-6.
  4. Hoogendijk Witte J G, Lips Paul, Dik Miranda G, Deeg Dorly J H, Beekman Aartjan T F, Penninx Brenda W J H. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008 Mai; 65, 5: 508-12.
  5. Stewart Robert, Hirani Vasant. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med. 2010 Sep; 72, 7: 608-12.
  6. Merete Cristina, Falcon Luis M, Tucker Katherine L. Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr. 2008 Jun; 27, 3: 421-7.
  7. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry. 2008 Apr;192(4):268-74.
  8. Morris Martha S, Fava Maurizio, Jacques Paul F, Selhub Jacob, Rosenberg Irwin H. Depression and folate status in the US Population. Psychother Psychosom. 2003 Mrz; 72, 2: 80-7.
  9. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry. 2002 Dec;159(12):2099-101.
  10. Jacka Felice N, Overland Simon, Stewart Robert, Tell Grethe S, Bjelland Ingvar, Mykletun Arnstein. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009 Jan; 43, 1: 45-52.
  11. Stanislawska M, Szkup-Jablonska M, Jurczak A, Wieder-Huszla S, Samochowiec A, Jasiewicz A, Nocen I, Augustyniuk K, Brodowska A, Karakiewicz B, Chlubek D, Grochans E. The severity of depressive symptoms vs. serum Mg and Zn levels in postmenopausal women. Biol Trace Elem Res. 2014 Jan; 157, 1: 30-5.
  12. Jung A, Spira D, Steinhagen-Thiessen E, Demuth I, Norman K. Zinc Deficiency Is associated With Depressive Symptoms-Results From the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2017 Aug 1;72(8):1149-1154.
  13. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biol Psychiatry. 2013 Dec 15;74(12):872-8.
  14. Grønli O, Kvamme JM, Friborg O, Wynn R. Zinc deficiency is common in several psychiatric disorders. PLoS One. 2013 Dec 19;8(12):e82793.
  15. Yary T, Aazami S. Dietary intake of zinc was inversely associated with depression. Biol Trace Elem Res. 2012 Mar;145(3):286-90.
  16. Amani R, Saeidi S, Nazari Z, Nematpour S. Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res. 2010 Nov;137(2):150-8.
  17. Grieger Jessica A, Nowson Caryl A, Ackland Leigh M. Nutritional and functional status indicators in residents of a long-term care facility. J Nutr Elder. 2009 Jan; 28, 1: 47-60.
  18. Colangelo, He, Whooley, Daviglus, Liu. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition. 2009 Feb.
  19. McNamara Robert K, Welge Jeffrey A. Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar Disord. 2106 Feb; 18, 3: 300-6.
  20. Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition. 2009 Oct;25(10):1011-9.
  21. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett. 2009;30(4):462-9.
  22. Braunwald, Fauci, Kasper, Hauser, Longo, Jameson. Harrisons Innere Medizin, 18. Auflage. In: M Dietel, J Dudenhausen, N Suttorp. ABW Wissenschaftsverlag, Berlin 2012
  23. Hoang MinhTu T, Defina Laura F, Willis Benjamin L, Leonard David S, Weiner Myron F, Brown E Sherwood. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc. 2011 Nov; 86, 11: 1050-5.
  24. Bertone-Johnson Elizabeth R, Powers Sally I, Spangler Leslie, Brunner Robert L, Michael Yvonne L, Larson Joseph C, Millen Amy E, Bueche Maria N, Salmoirago-Blotcher Elena, Liu Simin, Wassertheil-Smoller Sylvia, Ockene Judith K, Ockene Ira, Manson JoAnn E. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr. 2011 Okt; 94, 4: 1104-12.
  25. Milaneschi Yuri, Shardell Michelle, Corsi Anna Maria, Vazzana Rosamaria, Bandinelli Stefania, Guralnik Jack M, Ferrucci Luigi. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010 Jul; 95, 7: 3225-33.
  26. Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M. Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study. Psychosom Med. 2010 Oct;72(8):763-8.
  27. Biesalski HK: Vitamine, Spurenelemente und Minerale. Indikationen, Diagnostik, Therapie. 3. Auflage, Georg Thieme Verlag, München 2024
  28. Nanri A, Mizoue T, Matsushita Y, Sasaki S, Ohta M, Sato M, Mishima N. Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr. 2010 Mrz; 64, 3: 289-96.
  29. Cheungpasitporn W, Thongprayoon C, Mao M A, Srivali N, Ungprasert P, Varothai N, Sanguankeo A, Kittanamongkolchai W, Erickson S B. Hypomagnesaemia linked to depression: a systematic review and meta-analysis. Intern Med J. 2015 Apr; 45, 4: 436-40.
  30. Pasco Julie A, Jacka Felice N, Williams Lana J, Evans-Cleverdon Melinda, Brennan Sharon L, Kotowicz Mark A, Nicholson Geoffrey C, Ball Madeleine J, Berk Michael. Dietary selenium and major depression: a nested case-control study. Complement Ther Med. 2012 Jun; 20, 3: 119-23.
  31. Cope Elise C, Levenson Cathy W. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care. 2010 Nov; 13, 6: 685-9.
  32. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014 Apr 11;6(4):1501-18.
  33. Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, Li P, Davidson KW. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014 Apr;76(3):190-6.
  34. Lee HK, Kim SY, Sok SR. Effects of Multivitamin Supplements on Cognitive Function, Serum Homocysteine Level, and Depression of Korean Older Adults With Mild Cognitive Impairment in Care Facilities. J Nurs Scholarsh. 2016 May;48(3):223-31.
  35. Barragán-Rodríguez L, Rodríguez-Morán M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res. 2008 Dec;21(4):218-23. PMID: 19271419.
  36. Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M. The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord. 2012 Jan;136(1-2):e31-e39.
  37. Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Nutr Neurosci. 2015 May;18(4):162-8.
  38. Cope EC, Levenson CW. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care. 2010 Nov;13(6):685-9.
  39. Mocking R J T, Harmsen I, Assies J, Koeter M W J, Ruhé H G, Schene A H. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016 Mrz; 6: e756.
  40. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One. 2014 May 7;9(5):e96905.
  41. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009 Oct;28(5):525-42.
  42. Dashti-Khavidaki S, Gharekhani A, Khatami MR, Miri ES, Khalili H, Razeghi E, Hashemi-Nazari SS, Mansournia MA. Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients. Am J Ther. 2014 Jul-Aug;21(4):275-87.
  43. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, Montorfano G, Negroni M, Berra B, Politi P, Rizzo A M. Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life.
  44. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002 Nov;76(5):1172S-6S.
  45. Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosom Med. 2018 Feb/Mar;80(2):154-159.
  46. Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU. A review of current evidence for acetyl-l-carnitine in the treatment of depression. J Psychiatr Res. 2014 Jun;53:30-7.
  47. de Sousa-Muñoz RL, Filizola RG. Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome. Maturitas. 2009 May 20;63(1):89-93.
  48. Huang R, Wang K, Hu J. Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2016 Aug 6;8(8):483.
  49. Schaub AC, Schneider E, Vazquez-Castellanos JF, Schweinfurth N, Kettelhack C, Doll JPK, Yamanbaeva G, Mählmann L, Brand S, Beglinger C, Borgwardt S, Raes J, Schmidt A, Lang UE. Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry. 2022 Jun 3;12(1):227.
  50. Al-Karawi D, Al Mamoori DA, Tayyar Y. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials. Phytother Res. 2016 Feb;30(2):175-83.
  51. Lopresti AL, Drummond PD. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. J Affect Disord. 2017 Jan 1;207:188-196.
  52. Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. 2015 Mar 15;22(3):394-9. doi: 10.1016/j.phymed.2015.01.010. Epub 2015 Feb 23.

Autoren: Dr. med. Werner G. Gehring
Letzte Aktualisierung: 27.02.2025

stokkete – stock.adobe.com

Teilen
Drucken Zurück